From byte to bench to bed side – addressing large and complex data sets in biomedicine
KI NMA offers an advanced course in Network Medicine 19th-20th of October 2022. Participate on site in Erna Möller, Blockagången 16, Neo or online.
The 19th-20th October 2022 KI NMA will host an advanced course in three chapters with lectures, work shop and panel debates around the topic of Network Medicine and data sets in biomedicine.
The first day will focus on introduction to the field and historical perspective, followed by the Chapter 1: From single to couple to network and a work shop.
The second day will continue with Chapter 2: Untangle the complexity of pathophysiology by network analysis followed by Chapter 3: Network analysis empowers deep characterization of disease. The course will end with a panel debate regarding the pros and cons, and the innovative potential of Network Medicine.
The course will be offered both at Neo (Campus Flemingsberg) and streamed online. Registration is now closed.
The program will be updated continuously.
Paolo Parini, PhD, MD, Professor of Clinical chemistry at Department of Laboratory Medicine and Department of Medicine, Huddinge, Karolinska Institutet and academic coordinator for KI Network Medicine Alliance
Key note speaker: Edwin K. Silverman, M.D., Ph.D. Chief, Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Professor of Medicine, Harvard Medical School (USA)
Chair: Paolo Parini (KI) and Paola Paci (Sapienza University)
Mika Gustafsson, Professor in Bioinformatics, Department of Physics, Chemistry and Biology, Linköping University
Title: Network-analysis as tool for disease gene prioritization
Paola Paci, Associate Professor, Department of Computer, Control and Management Engineering, Sapienza University of Rome (Italy), Affiliated to Department of Laboratory Medicine, Karolinska Institutet
Title: SWIM: a network-based approach to human diseases
Let the data talk: The Single Cell Atlas
Presentation of the platform capabilities
Lu Pan, PhD student, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
Xuexin Li, MD, head of SCA Atlas, Department of Medical Biochemistry and Biophysics
Volker Lauschke, Associate Professor in Personalized Medicine and Drug Development, Department of Physiology and Pharmacology, Karolinska Institutet
Chair: Volker Lauschke (KI) and Matthias Schwab (University of Tübingen)
Jennifer Dines, MD, Vice President of Regulatory and Medical Affairs, Scipher Medicine (USA)
Title: Tackling Ineffective Drug Spend & Improving Patient Outcomes: Network-Based Multiomics Approach
Matthias Schwab, MD, Head of the Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart and Medical Director of the Department of Clinical Pharmacology, University Hospital, Tübingen (Germany)
Title: The future of drug therapy: Precision Medicine vs. Randomized Trials
Chair: Nanna Fyhrqvist, PhD, Assoc professor, senior researcher, research group leader, Institute of Environmental Medicine, Karolinska institutet and Ingemar Ernberg, PhD, MD, Professor in tumour biology at Department of Microbiology, Tumour and Cell biology, Karolinska Institutet
Harald Schmidt, PhD, MD, Professor at Department of Pharmacology and Personalised Medicine at Maastricht University’s Faculty of Health, Medicine and Life Sciences
Title: The end of medicine as we know it — The 6th Kondratiev wave
Päivi Östling, MD, Associate Professor, co-Principal Investigator, Scientific Lead Precision Medicine SciLifeLab, Dept of Oncology-Pathology, Karolinska Institutet
Title: Functional Precision Cancer Medicine
Moderator: Nanna Fyhrquist
Panel: Paolo Parini, Paola Paci, Volker Lauschke, Matthias Schwab, Ingemar Ernberg